Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: 410528-02-8, Rg-667, Ro-3300074, Sohonos, Clm-001, Ipn60120
Molecular Formula
C27H30N2O2
Molecular Weight
414.5  g/mol
InChI Key
YTFHCXIPDIHOIA-DHZHZOJOSA-N
FDA UNII
28K6I5M16G

Palovarotene is an orally available, selective retinoic acid receptor gamma agonist. Palovarotene selectively binds to the gamma retinoid agonist, thereby reducing inflammation and enhancing repair.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
4-[(E)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic acid
2.1.2 InChI
InChI=1S/C27H30N2O2/c1-26(2)12-13-27(3,4)24-17-22(18-29-15-5-14-28-29)21(16-23(24)26)11-8-19-6-9-20(10-7-19)25(30)31/h5-11,14-17H,12-13,18H2,1-4H3,(H,30,31)/b11-8+
2.1.3 InChI Key
YTFHCXIPDIHOIA-DHZHZOJOSA-N
2.1.4 Canonical SMILES
CC1(CCC(C2=C1C=C(C(=C2)C=CC3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C
2.1.5 Isomeric SMILES
CC1(CCC(C2=C1C=C(C(=C2)/C=C/C3=CC=C(C=C3)C(=O)O)CN4C=CC=N4)(C)C)C
2.2 Other Identifiers
2.2.1 UNII
28K6I5M16G
2.3 Synonyms
2.3.1 MeSH Synonyms

1. R-667

2. Rg-667

3. Ro-3300074

2.3.2 Depositor-Supplied Synonyms

1. 410528-02-8

2. Rg-667

3. Ro-3300074

4. Sohonos

5. Clm-001

6. Ipn60120

7. R-667

8. R 667

9. Ipn-60120

10. Ro 3300074

11. Ro3300074

12. 4-((1e)-2-(5,5,8,8-tetramethyl-3-(1h-pyrazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl)benzoic Acid

13. 4-[(e)-2-[5,5,8,8-tetramethyl-3-(pyrazol-1-ylmethyl)-6,7-dihydronaphthalen-2-yl]ethenyl]benzoic Acid

14. 28k6i5m16g

15. (e)-4-(2-(3-((1h-pyrazol-1-yl)methyl)-5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic Acid

16. Benzoic Acid, 4-((1e)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(1h-pyrazol-1-ylmethyl)-2-naphthalenyl)ethenyl)-

17. Palovarotene [usan]

18. Palovarotene [usan:inn]

19. Unii-28k6i5m16g

20. Palovarotene(r 667)

21. Palovarotene (usan/inn)

22. Palovarotene [inn]

23. Palovarotene [jan]

24. Palovarotene [who-dd]

25. Gtpl8276

26. Schembl4658931

27. Chembl2105648

28. Chebi:188559

29. Dtxsid301025696

30. Bcp16664

31. Ex-a3101

32. Who 9025

33. Zb1580

34. Zinc38467831

35. Cs-2031

36. Db12320

37. Ac-36331

38. Hy-14799

39. R667

40. R 667;ro 3300074

41. D09365

42. 528p028

43. A914214

44. Q15708269

45. 4-[(e)-2-(5,5,8,8-tetramethyl-3-pyrazol-1-ylmethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)vinyl]benzoic Acid

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 414.5 g/mol
Molecular Formula C27H30N2O2
XLogP36.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count5
Exact Mass414.230728204 g/mol
Monoisotopic Mass414.230728204 g/mol
Topological Polar Surface Area55.1 Ų
Heavy Atom Count31
Formal Charge0
Complexity662
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count1
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in emphysema.


Treatment of multiple osteochondromas


Treatment of fibrodysplasia ossificans progressiva


5 Pharmacology and Biochemistry
5.1 Pharmacology

R667 is an orally active, gamma selective retinoid agonist that shows promise as a treatment for emhysema.


5.2 ATC Code

M - Musculo-skeletal system

M09 - Other drugs for disorders of the musculo-skeletal system

M09A - Other drugs for disorders of the musculo-skeletal system

M09AX - Other drugs for disorders of the musculo-skeletal system

M09AX11 - Palovarotene


5.3 Mechanism of Action

Gamma-selective retinoic acid receptor agonist.